作为治疗点的AKT激酶
Dalal Hassan1,2, Craig W Menges3, Joseph R Testa3
1Nuclear Dynamics and Cancer Program, Cancer Epigenetics Institute, Institute for Cancer Research, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
Journal of experimental & clinical cancer research : CR
|November 29, 2024
概括
针对AKT通路,在细胞生长和疾病中至关重要,面临诸如耐药性等挑战. 异形特异性抑制剂和新的方法为癌症和其他疾病提供了有希望的,少毒的替代品.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 在PI3K/AKT信号通路调节基本的细胞过程.
- AKT活动的失调与各种病理有关,包括癌症,炎症和自身免疫性疾病.
研究的目的:
- 审查目前针对PI3K/AKT途径的策略.
- 讨论新的方法,包括异形特异性和突变选择性抑制剂,以改善治疗结果.
- 突出了对AKT抑制剂敏感性的更好的生物标志物的需要.
主要方法:
- 关于PI3K/AKT通路信号的文献综述.
- 对当前和新兴AKT抑制剂策略的分析.
- 讨论抵抗机制和非目标效应.
主要成果:
- 传统的泛-AKT抑制剂面临的挑战是耐药性和毒性.
- 以异形为中心的向和突变选择性共价全性AKT抑制剂 (CAAI) 显示出增强疗效和减少副作用的潜力.
- 开发可靠的生物标志物对于预测患者反应至关重要.
结论:
- 向特定的AKT异型或突变可能比泛AKT抑制提供更有效和更安全的治疗策略.
- 新型向方法和改进的生物标志物对于推进AKT向疗法的发展至关重要.
- 对异形特异和等位基选择性抑制剂的进一步研究有望用于治疗AKT驱动的疾病,包括癌症和免疫疗法应用.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


